Buyer Name: NHS South East London Integrated Care Board
Buyer Address: London, UKI45, United Kingdom
Contact Email: hub.queries@nhs.net
Buyer Name: NHS South East London Integrated Care Board
Buyer Address: London, UKI45, United Kingdom
Contact Email: hub.queries@nhs.net
To ensure patients starting tirzepatide (Mounjaro®) receive holistic, person-centred care that includes Behavioural Support for Obesity Prescribing (BSOP) commissioed by NHSE (Lambeth) Being awarded as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.
No linked documents found for this notice.
Lot Description: To ensure patients starting tirzepatide (Mounjaro®) receive holistic, person-centred care that includes Behavioural Support for Obesity Prescribing (BSOP) commissioed by NHSE. Being awarded as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Award decision makers: South East London Integrated Care Board There were no conflict of interest identified in the decision making process. An urgent award or modification is to be made by the relevant authority as the following are true: • The award or modification must be made urgently. • The reason for the urgency was not foreseeable by and is not attributable to the relevant authority. • Delaying the award to conduct a full application of the PSR would be likely to pose a risk to patient or public safety. Urgent award is required as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.
Lot 1 Status: cancelled
Lot 1 Has Options: No
{
"awards": [
{
"id": "081973-2025-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-168903",
"name": "Lambeth Healthcare Ltd"
}
]
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"buyer": {
"id": "GB-FTS-107885",
"name": "NHS South East London Integrated Care Board"
},
"contracts": [
{
"awardID": "081973-2025-1",
"dateSigned": "2025-12-11T00:00:00Z",
"id": "081973-2025-1",
"status": "active",
"value": {
"amount": 77520,
"currency": "GBP"
}
}
],
"date": "2025-12-11T13:00:39Z",
"description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period.\nAward decision makers: South East London Integrated Care Board\nThere were no conflict of interest identified in the decision making process.\nAn urgent award or modification is to be made by the relevant authority as the following are true:\n\u2022 The award or modification must be made urgently.\n\u2022 The reason for the urgency was not foreseeable by and is not attributable to the relevant authority.\n\u2022 Delaying the award to conduct a full application of the PSR would be likely to pose a risk to patient or public safety.\nAn urgent award is required as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort",
"id": "081973-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05f3cd",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "London",
"region": "UKI45"
},
"contactPoint": {
"email": "hub.queries@nhs.net"
},
"details": {
"buyerProfile": "https://www.selondonics.org/icb/",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "https://www.selondonics.org/icb/"
},
"id": "GB-FTS-107885",
"identifier": {
"legalName": "NHS South East London Integrated Care Board",
"noIdentifierRationale": "notOnAnyRegister"
},
"name": "NHS South East London Integrated Care Board",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SW9 6AF",
"region": "UKI45",
"streetAddress": "Akerman Health Centre 60 Patmos Road"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-168903",
"identifier": {
"legalName": "Lambeth Healthcare Ltd",
"noIdentifierRationale": "notOnAnyRegister"
},
"name": "Lambeth Healthcare Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "London"
},
"id": "GB-FTS-107885",
"identifier": {
"legalName": "NHS South East London Integrated Care Board"
},
"name": "NHS South East London Integrated Care Board",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Health services",
"id": "85100000",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "To ensure patients starting tirzepatide (Mounjaro\u00ae) receive holistic, person-centred care that includes Behavioural Support for Obesity Prescribing (BSOP) commissioed by NHSE (Lambeth)\nBeing awarded as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.",
"id": "PRN01624",
"items": [
{
"additionalClassifications": [
{
"description": "Health services",
"id": "85100000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKI"
}
],
"deliveryLocation": {
"description": "Lambeth Healthcare Ltd\nAkerman Health Centre 60 Patmos Road, London \nSW9 6AF"
},
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"description": "To ensure patients starting tirzepatide (Mounjaro\u00ae) receive holistic, person-centred care that includes Behavioural Support for Obesity Prescribing (BSOP) commissioed by NHSE.\nBeing awarded as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period.\nAward decision makers: South East London Integrated Care Board\nThere were no conflict of interest identified in the decision making process.\nAn urgent award or modification is to be made by the relevant authority as the following are true:\n\u2022 The award or modification must be made urgently.\n\u2022 The reason for the urgency was not foreseeable by and is not attributable to the relevant authority.\n\u2022 Delaying the award to conduct a full application of the PSR would be likely to pose a risk to patient or public safety.\nUrgent award is required as any delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.",
"hasOptions": false,
"id": "1",
"status": "cancelled"
}
],
"mainProcurementCategory": "services",
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "Award of a contract without prior publication of a call for competition. An Urgent award is required.\nAny delay to the award would significantly extend the timeline for the nationally mandated Mounjaro rollout, with attendant risks to the health of the eligible cohort.",
"procurementMethodRationaleClassifications": [
{
"description": "No tenders or no suitable tenders/requests to participate in response to open procedure",
"id": "D_PROC_OPEN",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"status": "complete",
"title": "Primary Care Pathway for Tirzepatide Lambeth"
}
}